A fusion intermediate gp41 immunogen elicits neutralizing antibodies to HIV-1

Journal of Biological Chemistry

Volumn 289, Issue 43, 2014, Pages 29912-29926

  Lai, Rachel P J ^a,i   Hock, Miriam ^b,c   Radzimanowski, Jens ^b,c   Tonks, Paul ^a   Hulsik, David Lutje ^b,c,j   Effantin, Gregory ^b,c   Seilly, David J ^a   Dreja, Hanna ^a,k   Kliche, Alexander ^d   Wagner, Ralf ^d   Barnett, Susan W ^e   Tumba, Nancy ^f   Morris, Lynn ^f   LaBranche, Celia C ^g   Montefiori, David C ^g   Seaman, Michael S ^h   Heeney, Jonathan L ^a   Weissenhorn, Winfried ^b,c  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIV GRENOBLE ALPES   (France)

^c CNRS   (France)

^d UNIVERSITY OF REGENSBURG   (Germany)

^e Novartis Vaccines and Diagnostics Inc   (United States)

^f NATIONAL INSTITUTE FOR COMMUNICABLE DISEASES   (South Africa)

^g DUKE UNIVERSITY MEDICAL CENTER   (United States)

^h BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

ⁱ NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^j Aduro BioTech Inc   (United States)

^k ABCAM PLC   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; CELL MEMBRANES; DISEASES; IMMUNIZATION; LIPOSOMES; VIRUSES; X RAY SCATTERING;

ENVELOPE GLYCOPROTEINS; EXTENDED STRUCTURES; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNODEFICIENCY VIRUS; INTERMEDIATE CONFORMATION; MEMBRANE INTERACTIONS; NEUTRALIZING ANTIBODIES; SMALL ANGLE X-RAY SCATTERING;

ANTIBODIES;

CARBOMER; CARBOPOL 971P; CYSTEINE; GLYCOPROTEIN GP 41; IMMUNOGLOBULIN G ANTIBODY; LIPOSOME; MIFAMURTIDE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 10E8; MONOCLONAL ANTIBODY 2F5; MONOCLONAL ANTIBODY 4E10; UNCLASSIFIED DRUG; ANTISERUM; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; IMMUNOGLOBULIN G; NEUTRALIZING ANTIBODY; PROTEOLIPID; PROTEOLIPOSOMES;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CARBOXY TERMINAL SEQUENCE; CIRCULAR DICHROISM; CONTROLLED STUDY; FEMALE; GUINEA PIG; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNIZATION; IMMUNOGENICITY; MEMBRANE PROXIMAL EXTERNAL REGION; NONHUMAN; PROTEIN ANALYSIS; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; PROTEIN STRUCTURE; RADIATION SCATTERING; SURFACE PLASMON RESONANCE; VIRUS NEUTRALIZATION; VIRUS REPLICATION; AMINO ACID SEQUENCE; ANIMAL; ANTIBODY AFFINITY; CHEMISTRY; HUMAN; IMMUNOLOGY; METABOLISM; MOLECULAR GENETICS; NEUTRON DIFFRACTION; PROTEIN TERTIARY STRUCTURE; SMALL ANGLE SCATTERING; ULTRASTRUCTURE;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODY AFFINITY; FEMALE; GUINEA PIGS; HIV ANTIBODIES; HIV ENVELOPE PROTEIN GP41; HUMANS; IMMUNE SERA; IMMUNIZATION; IMMUNOGLOBULIN G; MOLECULAR SEQUENCE DATA; NEUTRON DIFFRACTION; PROTEIN STRUCTURE, TERTIARY; PROTEOLIPIDS; SCATTERING, SMALL ANGLE;

EID: 84908193527     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M114.569566     Document Type: Article

References (117)

1. Alam, S. M., Scearce, R. M., Parks, R. J., Plonk, K., Plonk, S. G., Sutherland, L. L., Gorny, M. K., Zolla-Pazner, S., Vanleeuwen, S., Moody, M. A., Xia, S. M., Montefiori, D. C., Tomaras, G. D., Weinhold, K. J., Karim, S. A., Hicks, C. B., Liao, H. X., Robinson, J., Shaw, G. M., and Haynes, B. F. (2008) Human immunodeficiency virus type 1 gp41 antibodies that mask membrane proximal region epitopes: antibody binding kinetics, induction, and potential for regulation in acute infection. J. Virol. 82, 115-125
2. Liao, H. X., Chen, X., Munshaw, S., Zhang, R., Marshall, D. J., Vandergrift, N., Whitesides, J. F., Lu, X., Yu, J. S., Hwang, K. K., Gao, F., Markowitz, M., Heath, S. L., Bar, K. J., Goepfert, P. A., Montefiori, D. C., Shaw, G. C., Alam, S. M., Margolis, D. M., Denny, T. N., Boyd, S. D., Marshal, E., Egholm, M., Simen, B. B., Hanczaruk, B., Fire, A. Z., Voss, G., Kelsoe, G., Tomaras, G. D., Moody, M. A., Kepler, T. B., and Haynes, B. F. (2011) Initial antibodies binding to HIV-1 gp41 in acutely infected subjects are polyreactive and highly mutated. J. Exp. Med. 208, 2237-2249
3. Bar, K. J., Tsao, C. Y., Iyer, S. S., Decker, J. M., Yang, Y., Bonsignori, M., Chen, X., Hwang, K. K., Montefiori, D. C., Liao, H. X., Hraber, P., Fischer, W., Li, H., Wang, S., Sterrett, S., Keele, B. F., Ganusov, V. V., Perelson, A. S., Korber, B. T., Georgiev, I., McLellan, J. S., Pavlicek, J. W., Gao, F., Haynes, B. F., Hahn, B. H., Kwong, P. D., and Shaw, G. M. (2012) Early low-titer neutralizing antibodies impede HIV-1 replication and select for virus escape. PLoS Pathog. 8, e1002721
4. Corti, D., Langedijk, J. P., Hinz, A., Seaman, M. S., Vanzetta, F., Fernandez-Rodriguez, B. M., Silacci, C., Pinna, D., Jarrossay, D., Balla-Jhagjhoorsingh, S., Willems, B., Zekveld, M. J., Dreja, H., O'Sullivan, E., Pade, C., Orkin, C., Jeffs, S. A., Montefiori, D. C., Davis, D., Weissenhorn, W., McKnight, A., Heeney, J. L., Sallusto, F., Sattentau, Q. J., Weiss, R. A., and Lanzavecchia, A. (2010) Analysis of memory B cell responses and isolation of novel monoclonal antibodies with neutralizing breadth from HIV-1-infected individuals. PLoS One 5, e8805
5. Scheid, J. F., Mouquet, H., Feldhahn, N., Seaman, M. S., Velinzon, K., Pietzsch, J., Ott, R. G., Anthony, R. M., Zebroski, H., Hurley, A., Phogat, A., Chakrabarti, B., Li, Y., Connors, M., Pereyra, F., Walker, B. D., Wardemann, H., Ho, D., Wyatt, R. T., Mascola, J. R., Ravetch, J. V., and Nussenzweig, M. C. (2009) Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals. Nature 458, 636-640
6. Wu, X., Yang, Z. Y., Li, Y., Hogerkorp, C. M., Schief, W. R., Seaman, M. S., Zhou, T., Schmidt, S. D., Wu, L., Xu, L., Longo, N. S., McKee, K., O'Dell, S., Louder, M. K., Wycuff, D. L., Feng, Y., Nason, M., Doria-Rose, N., Connors, M., Kwong, P. D., Roederer, M., Wyatt, R. T., Nabel, G. J., and Mascola, J. R. (2010) Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1. Science 329, 856-861
7. Scheid, J. F., Mouquet, H., Ueberheide, B., Diskin, R., Klein, F., Oliveira, T. Y., Pietzsch, J., Fenyo, D., Abadir, A., Velinzon, K., Hurley, A., Myung, S., Boulad, F., Poignard, P., Burton, D. R., Pereyra, F., Ho, D. D., Walker, B. D., Seaman, M. S., Bjorkman, P. J., Chait, B. T., and Nussenzweig, M. C. (2011) Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 binding. Science 333, 1633-1637
8. Diskin, R., Scheid, J. F., Marcovecchio, P. M., West, A. P., Jr., Klein, F., Gao, H., Gnanapragasam, P. N., Abadir, A., Seaman, M. S., Nussenzweig, M. C., and Bjorkman, P. J. (2011) Increasing the potency and breadth of an HIV antibody by using structure-based rational design. Science 334, 1289-1293
9. Liao, H. X., Lynch, R., Zhou, T., Gao, F., Alam, S. M., Boyd, S. D., Fire, A. Z., Roskin, K. M., Schramm, C. A., Zhang, Z., Zhu, J., Shapiro, L., NISC Comparative Sequencing Program, Mullikin, J. C., Gnanakaran, S., Hraber, P., Wiehe, K., Kelsoe, G., Yang, G., Xia, S. M., Montefiori, D. C., Parks, R., Lloyd, K. E., Scearce, R. M., Soderberg, K. A., Cohen, M., Kamanga, G., Louder, M. K., Tran, L. M., Chen, Y., Cai, F., Chen, S., Moquin, S., Du, X., Joyce, M. G., Srivatsan, S., Zhang, B., Zheng, A., Shaw, G. M., Hahn, B. H., Kepler, T. B., Korber, B. T., Kwong, P. D., Mascola, J. R., and Haynes, B. F. (2013) Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus. Nature 496, 469-476
10. Walker, L. M., Phogat, S. K., Chan-Hui, P. Y., Wagner, D., Phung, P., Goss, J. L., Wrin, T., Simek, M. D., Fling, S., Mitcham, J. L., Lehrman, J. K., Priddy, F. H., Olsen, O. A., Frey, S. M., Hammond, P. W., Protocol G Principal Investigators, Kaminsky, S., Zamb, T., Moyle, M., Koff, W. C., Poignard, P., and Burton, D. R. (2009) Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target. Science 326, 285-289
11. Walker, L. M., Huber, M., Doores, K. J., Falkowska, E., Pejchal, R., Julien, J. P., Wang, S. K., Ramos, A., Chan-Hui, P. Y., Moyle, M., Mitcham, J. L., Hammond, P. W., Olsen, O. A., Phung, P., Fling, S., Wong, C. H., Phogat, S., Wrin, T., Simek, M. D., Protocol G Principal Investigators, Koff, W. C., Wilson, I. A., Burton, D. R., and Poignard, P. (2011) Broad neutralization coverage of HIV by multiple highly potent antibodies. Nature 477, 466-470
12. McLellan, J. S., Pancera, M., Carrico, C., Gorman, J., Julien, J. P., Khayat, R., Louder, R., Pejchal, R., Sastry, M., Dai, K., O'Dell, S., Patel, N., Shahzad-ul-Hussan, S., Yang, Y., Zhang, B., Zhou, T., Zhu, J., Boyington, J. C., Chuang, G. Y., Diwanji, D., Georgiev, I., Kwon, Y. D., Lee, D., Louder, M. K., Moquin, S., Schmidt, S. D., Yang, Z. Y., Bonsignori, M., Crump, J. A., Kapiga, S. H., Sam, N. E., Haynes, B. F., Burton, D. R., Koff, W. C., Walker, L. M., Phogat, S., Wyatt, R., Orwenyo, J., Wang, L. X., Arthos, J., Bewley, C. A., Mascola, J. R., Nabel, G. J., Schief, W. R., Ward, A. B., Wilson, I. A., and Kwong, P. D. (2011) Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9. Nature 480, 336-343
13. Pancera, M., Shahzad-Ul-Hussan, S., Doria-Rose, N. A., McLellan, J. S., Bailer, R. T., Dai, K., Loesgen, S., Louder, M. K., Staupe, R. P., Yang, Y., Zhang, B., Parks, R., Eudailey, J., Lloyd, K. E., Blinn, J., Alam, S. M., Haynes, B. F., Amin, M. N., Wang, L. X., Burton, D. R., Koff, W. C., Nabel, G. J., Mascola, J. R., Bewley, C. A., and Kwong, P. D. (2013) Structural basis for diverse N-glycan recognition by HIV-1-neutralizing V1-V2- directed antibody PG16. Nat. Struct. Mol. Biol. 20, 804-813
14. Huang, J., Ofek, G., Laub, L., Louder, M. K., Doria-Rose, N. A., Longo, N. S., Imamichi, H., Bailer, R. T., Chakrabarti, B., Sharma, S. K., Alam, S. M., Wang, T., Yang, Y., Zhang, B., Migueles, S. A., Wyatt, R., Haynes, B. F., Kwong, P. D., Mascola, J. R., and Connors, M. (2012) Broad and potent neutralization of HIV-1 by a gp41-specific human antibody. Nature 491, 406-412
15. Klein, F., Diskin, R., Scheid, J. F., Gaebler, C., Mouquet, H., Georgiev, I. S., Pancera, M., Zhou, T., Incesu, R. B., Fu, B. Z., Gnanapragasam, P. N., Oliveira, T. Y., Seaman, M. S., Kwong, P. D., Bjorkman, P. J., and Nussenzweig, M. C. (2013) Somatic mutations of the immunoglobulin framework are generally required for broad and potent HIV-1 neutralization. Cell 153, 126-138
16. Muñoz-Barroso, I., Salzwedel, K., Hunter, E., and Blumenthal, R. (1999) Role of the membrane-proximal domain in the initial stages of human immunodeficiency virus type 1 envelope glycoprotein-mediated membrane fusion. J. Virol. 73, 6089-6092
17. Zwick, M. B., Labrijn, A. F., Wang, M., Spenlehauer, C., Saphire, E. O., Binley, J. M., Moore, J. P., Stiegler, G., Katinger, H., Burton, D. R., and Parren, P. W. (2001) Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41. J. Virol. 75, 10892-10905
18. Salzwedel, K., West, J. T., and Hunter, E. (1999)Aconserved tryptophanrich motif in the membrane-proximal region of the human immunodeficiency virus type 1 gp41 ectodomain is important for Env-mediated fusion and virus infectivity. J. Virol. 73, 2469-2480
19. Muster, T., Steindl, F., Purtscher, M., Trkola, A., Klima, A., Himmler, G., Rüker, F., and Katinger, H. (1993) A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1. J. Virol. 67, 6642-6647
20. Stiegler, G., Kunert, R., Purtscher, M., Wolbank, S., Voglauer, R., Steindl, F., and Katinger, H. (2001) A potent cross-clade neutralizing human monoclonal antibody against a novel epitope on gp41 of human immunodeficiency virus type 1. AIDS Res. Hum. Retroviruses 17, 1757-1765
21. Nelson, J. D., Brunel, F. M., Jensen, R., Crooks, E. T., Cardoso, R. M., Wang, M., Hessell, A., Wilson, I. A., Binley, J. M., Dawson, P. E., Burton, D. R., and Zwick, M. B. (2007) An affinity-enhanced neutralizing antibody against the membrane-proximal external region of human immunodeficiency virus type 1 gp41 recognizes an epitope between those of 2F5 and 4E10. J. Virol. 81, 4033-4043
22. Ofek, G., Tang, M., Sambor, A., Katinger, H., Mascola, J. R., Wyatt, R., and Kwong, P. D. (2004) Structure and mechanistic analysis of the anti-human immunodeficiency virus type 1 antibody 2F5 in complex with its gp41 epitope. J. Virol. 78, 10724-10737
23. Cardoso, R. M., Zwick, M. B., Stanfield, R. L., Kunert, R., Binley, J. M., Katinger, H., Burton, D. R., and Wilson, I. A. (2005) Broadly neutralizing anti-HIV antibody 4E10 recognizes a helical conformation of a highly conserved fusion-associated motif in gp41. Immunity 22, 163-173
24. Pejchal, R., Gach, J. S., Brunel, F. M., Cardoso, R. M., Stanfield, R. L., Dawson, P. E., Burton, D. R., Zwick, M. B., and Wilson, I. A. (2009) A conformational switch in human immunodeficiency virus gp41 revealed by the structures of overlapping epitopes recognized by neutralizing antibodies. J. Virol. 83, 8451-8462
25. Haynes, B. F., Fleming, J., St Clair, E. W., Katinger, H., Stiegler, G., Kunert, R., Robinson, J., Scearce, R. M., Plonk, K., Staats, H. F., Ortel, T. L., Liao, H. X., and Alam, S. M. (2005) Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies. Science 308, 1906-1908
26. Alam, S. M., McAdams, M., Boren, D., Rak, M., Scearce, R. M., Gao, F., Camacho, Z. T., Gewirth, D., Kelsoe, G., Chen, P., and Haynes, B. F. (2007) The role of antibody polyspecificity and lipid reactivity in binding of broadly neutralizing anti-HIV-1 envelope human monoclonal antibodies 2F5 and 4E10 to glycoprotein 41 membrane proximal envelope epitopes. J. Immunol. 178, 4424-4435
27. Ofek, G., McKee, K., Yang, Y., Yang, Z. Y., Skinner, J., Guenaga, F. J., Wyatt, R., Zwick, M. B., Nabel, G. J., Mascola, J. R., and Kwong, P. D. (2010) Relationship between antibody 2F5 neutralization of HIV-1 and hydrophobicity of its heavy chain third complementarity-determining region. J. Virol. 84, 2955-2962
28. Scherer, E. M., Leaman, D. P., Zwick, M. B., McMichael, A. J., and Burton, D. R. (2010) Aromatic residues at the edge of the antibody combining site facilitate viral glycoprotein recognition through membrane interactions. Proc. Natl. Acad. Sci. U.S.A. 107, 1529-1534
29. Alam, S. M., Morelli, M., Dennison, S. M., Liao, H. X., Zhang, R., Xia, S. M., Rits-Volloch, S., Sun, L., Harrison, S. C., Haynes, B. F., and Chen, B. (2009) Role of HIV membrane in neutralization by two broadly neutralizing antibodies. Proc. Natl. Acad. Sci. U.S.A. 106, 20234-20239
30. Julien, J. P., Huarte, N., Maeso, R., Taneva, S. G., Cunningham, A., Nieva, J. L., and Pai, E. F. (2010) Ablation of the complementarity-determining region H3 apex of the anti-HIV-1 broadly neutralizing antibody 2F5 abrogates neutralizing capacity without affecting core epitope binding. J. Virol. 84, 4136-4147
31. Singh, H., Henry, K. A., Wu, S. S., Chruscinski, A., Utz, P. J., and Scott, J. K. (2011) Reactivity profiles of broadly neutralizing anti-HIV-1 antibodies are distinct from those of pathogenic autoantibodies. AIDS 25, 1247-1257
32. Haynes, B. F., Nicely, N. I., and Alam, S. M. (2010) HIV-1 autoreactive antibodies: are they good or bad for HIV-1 prevention? Nat. Struct. Mol. Biol. 17, 543-545
33. Verkoczy, L., Diaz, M., Holl, T. M., Ouyang, Y. B., Bouton-Verville, H., Alam, S. M., Liao, H. X., Kelsoe, G., and Haynes, B. F. (2010) Autoreactivity in an HIV-1 broadly reactive neutralizing antibody variable region heavy chain induces immunologic tolerance. Proc. Natl. Acad. Sci. U.S.A. 107, 181-186
34. Chen, Y., Zhang, J., Hwang, K. K., Bouton-Verville, H., Xia, S. M., Newman, A., Ouyang, Y. B., Haynes, B. F., and Verkoczy, L. (2013) Common tolerance mechanisms, but distinct cross-reactivities associated with gp41 and lipids, limit production of HIV-1 broad neutralizing antibodies 2F5 and 4E10. J. Immunol. 191, 1260-1275
35. Chen, J., Frey, G., Peng, H., Rits-Volloch, S., Garrity, J., Seaman, M. S., and Chen, B. (2014) Mechanism of HIV-1 neutralization by antibodies targeting a membrane-proximal region of gp41. J. Virol. 88, 1249-1258
36. Shen, X., Parks, R. J., Montefiori, D. C., Kirchherr, J. L., Keele, B. F., Decker, J. M., Blattner, W. A., Gao, F., Weinhold, K. J., Hicks, C. B., Greenberg, M. L., Hahn, B. H., Shaw, G. M., Haynes, B. F., and Tomaras, G. D. (2009) In vivo gp41 antibodies targeting the 2F5 monoclonal antibody epitope mediate human immunodeficiency virus type 1 neutralization breadth. J. Virol. 83, 3617-3625
37. Pietzsch, J., Scheid, J. F., Mouquet, H., Seaman, M. S., Broder, C. C., and Nussenzweig, M. C. (2010) Anti-gp41 antibodies cloned from HIV-infected patients with broadly neutralizing serologic activity. J. Virol. 84, 5032-5042
38. Zhu, Z., Qin, H. R., Chen, W., Zhao, Q., Shen, X., Schutte, R., Wang, Y., Ofek, G., Streaker, E., Prabakaran, P., Fouda, G. G., Liao, H. X., Owens, J., Louder, M., Yang, Y., Klaric, K. A., Moody, M. A., Mascola, J. R., Scott, J. K., Kwong, P. D., Montefiori, D., Haynes, B. F., Tomaras, G. D., and Dimitrov, D. S. (2011) Cross-reactive HIV-1-neutralizing human monoclonal antibodies identified from a patient with 2F5-like antibodies. J. Virol. 85, 11401-11408
39. Morris, L., Chen, X., Alam, M., Tomaras, G., Zhang, R., Marshall, D. J., Chen, B., Parks, R., Foulger, A., Jaeger, F., Donathan, M., Bilska, M., Gray, E. S., Abdool Karim, S. S., Kepler, T. B., Whitesides, J., Montefiori, D., Moody, M. A., Liao, H. X., and Haynes, B. F. (2011) Isolation of a human anti-HIV gp41 membrane proximal region neutralizing antibody by antigen-specific single B cell sorting. PLoS One 6, e23532
40. Hessell, A. J., Rakasz, E. G., Tehrani, D. M., Huber, M., Weisgrau, K. L., Landucci, G., Forthal, D. N., Koff, W. C., Poignard, P., Watkins, D. I., and Burton, D. R. (2010) Broadly neutralizing monoclonal antibodies 2F5 and 4E10 directed against the human immunodeficiency virus type 1 gp41 membrane-proximal external region protect against mucosal challenge by simian-human immunodeficiency virus SHIVBa-L. J. Virol. 84, 1302-1313
41. Frey, G., Peng, H., Rits-Volloch, S., Morelli, M., Cheng, Y., and Chen, B. (2008) A fusion-intermediate state of HIV-1 gp41 targeted by broadly neutralizing antibodies. Proc. Natl. Acad. Sci. U.S.A. 105, 3739-3744
42. Dimitrov, A. S., Jacobs, A., Finnegan, C. M., Stiegler, G., Katinger, H., and Blumenthal, R. (2007) Exposure of the membrane-proximal external region of HIV-1 gp41 in the course of HIV-1 envelope glycoprotein-mediated fusion. Biochemistry 46, 1398-1401
43. Julien, J. P., Cupo, A., Sok, D., Stanfield, R. L., Lyumkis, D., Deller, M. C., Klasse, P. J., Burton, D. R., Sanders, R. W., Moore, J. P., Ward, A. B., and Wilson, I. A. (2013) Crystal structure of a soluble cleaved HIV-1 envelope trimer. Science 342, 1477-1483
44. Lyumkis, D., Julien, J. P., de Val, N., Cupo, A., Potter, C. S., Klasse, P. J., Burton, D. R., Sanders, R. W., Moore, J. P., Carragher, B., Wilson, I. A., and Ward, A. B. (2013) Cryo-EM structure of a fully glycosylated soluble cleaved HIV-1 envelope trimer. Science 342, 1484-1490
45. Bartesaghi, A., Merk, A., Borgnia, M. J., Milne, J. L., and Subramaniam, S. (2013) Prefusion structure of trimeric HIV-1 envelope glycoprotein determined by cryo-electron microscopy. Nat. Struct. Mol. Biol. 20, 1352-1357
46. Merk, A., and Subramaniam, S. (2013) HIV-1 envelope glycoprotein structure. Curr. Opin. Struct. Biol. 23, 268-276
47. Chan, D. C., Fass, D., Berger, J. M., and Kim, P. S. (1997) Core structure of gp41 from the HIV envelope glycoprotein. Cell 89, 263-273
48. Weissenhorn, W., Dessen, A., Harrison, S. C., Skehel, J. J., and Wiley, D. C. (1997) Atomic structure of the ectodomain from HIV-1 gp41. Nature 387, 426-430
49. Caffrey, M., Cai, M., Kaufman, J., Stahl, S. J., Wingfield, P. T., Gronenborn, A. M., and Clore, G. M. (1997) Determination of the secondary structure and global topology of the 44 kDa ectodomain of gp41 of the simian immunodeficiency virus by multidimensional nuclear magnetic resonance spectroscopy. J. Mol. Biol. 271, 819-826
50. Buzon, V., Natrajan, G., Schibli, D., Campelo, F., Kozlov, M. M., and Weissenhorn, W. (2010) Crystal structure of HIV-1 gp41 including both fusion peptide and membrane proximal external regions. PLoS Pathog. 6, e1000880
51. Oster, A. M., Pieniazek, D., Zhang, X., Switzer, W. M., Ziebell, R. A., Mena, L. A., Wei, X., Johnson, K. L., Singh, S. K., Thomas, P. E., Elmore, K. A., and Heffelfinger, J. D. (2011) Demographic but not geographic insularity in HIV transmission among young black MSM. AIDS 25, 2157-2165
52. Sun, Z. Y., Oh, K. J., Kim, M., Yu, J., Brusic, V., Song, L., Qiao, Z., Wang, J. H., Wagner, G., and Reinherz, E. L. (2008) HIV-1 broadly neutralizing antibody extracts its epitope from a kinked gp41 ectodomain region on the viral membrane. Immunity 28, 52-63
53. Kim, M., Sun, Z. Y., Rand, K. D., Shi, X., Song, L., Cheng, Y., Fahmy, A. F., Majumdar, S., Ofek, G., Yang, Y., Kwong, P. D., Wang, J. H., Engen, J. R., Wagner, G., and Reinherz, E. L. (2011) Antibody mechanics on a membrane-bound HIV segment essential for GP41-targeted viral neutralization. Nat. Struct. Mol. Biol. 18, 1235-1243
54. Montero, M., van Houten, N. E., Wang, X., and Scott, J. K. (2008) The membrane-proximal external region of the human immunodeficiency virus type 1 envelope: dominant site of antibody neutralization and target for vaccine design. Microbiol. Mol. Biol. Rev. 72, 54-84
55. Decroix, N., Hocini, H., Quan, C. P., Bellon, B., Kazatchkine, M. D., and Bouvet, J. P. (2001) Induction in mucosa of IgG and IgA antibodies against parenterally administered soluble immunogens. Scand. J. Immunol. 53, 401-409
56. Joyce, J. G., Hurni, W. M., Bogusky, M. J., Garsky, V. M., Liang, X., Citron, M. P., Danzeisen, R. C., Miller, M. D., Shiver, J. W., and Keller, P. M. (2002) Enhancement of α-helicity in the HIV-1 inhibitory peptide DP178 leads to an increased affinity for human monoclonal antibody 2F5 but does not elicit neutralizing responses in vitro. Implications for vaccine design. J. Biol. Chem. 277, 45811-45820
57. Liao, M., Lu, Y., Xiao, Y., Dierich, M. P., and Chen, Y. (2000) Induction of high level of specific antibody response to the neutralizing epitope ELDKWA on HIV-1 gp41 by peptide-vaccine. Peptides 21, 463-468
58. McGaughey, G. B., Citron, M., Danzeisen, R. C., Freidinger, R. M., Garsky, V. M., Hurni, W. M., Joyce, J. G., Liang, X., Miller, M., Shiver, J., and Bogusky, M. J. (2003) HIV-1 vaccine development: constrained peptide immunogens show improved binding to the anti-HIV-1 gp41 MAb. Biochemistry 42, 3214-3223
59. Ni, J., Powell, R., Baskakov, I. V., DeVico, A., Lewis, G. K., and Wang, L. X. (2004) Synthesis, conformation, and immunogenicity of monosaccharide-centered multivalent HIV-1 gp41 peptides containing the sequence of DP178. Bioorg. Med. Chem. 12, 3141-3148
60. Matoba, N., Geyer, B. C., Kilbourne, J., Alfsen, A., Bomsel, M., and Mor, T. S. (2006) Humoral immune responses by prime-boost heterologous route immunizations with CTB-MPR(649-684), a mucosal subunit HIV/AIDS vaccine candidate. Vaccine 24, 5047-5055
61. Zhou, M., Kostoula, I., Brill, B., Panou, E., Sakarellos-Daitsiotis, M., and Dietrich, U. (2012) Prime boost vaccination approaches with different conjugates of a new HIV-1 gp41 epitope encompassing the membrane proximal external region induce neutralizing antibodies in mice. Vaccine 30, 1911-1916
62. Guenaga, J., Dosenovic, P., Ofek, G., Baker, D., Schief, W. R., Kwong, P. D., Karlsson Hedestam, G. B., and Wyatt, R. T. (2011) Heterologous epitope-scaffold prime:boosting immuno-focuses B cell responses to the HIV-1 gp41 2F5 neutralization determinant. PLoS One 6, e16074
63. Ofek, G., Guenaga, F. J., Schief, W. R., Skinner, J., Baker, D., Wyatt, R., and Kwong, P. D. (2010) Elicitation of structure-specific antibodies by epitope scaffolds. Proc. Natl. Acad. Sci. U.S.A. 107, 17880-17887
64. Strasz, N., Morozov, V. A., Kreutzberger, J., Keller, M., Eschricht, M., and Denner, J. (2014) Immunization with hybrid proteins containing the membrane proximal external region of HIV-1. AIDS Res. Hum. Retroviruses 30, 498-508
65. Ye, L., Wen, Z., Dong, K., Wang, X., Bu, Z., Zhang, H., Compans, R. W., and Yang, C. (2011) Induction of HIV neutralizing antibodies against the MPER of the HIV envelope protein by HA/gp41 chimeric protein-based DNA and VLP vaccines. PLoS One 6, e14813
66. Muster, T., Ferko, B., Klima, A., Purtscher, M., Trkola, A., Schulz, P., Grassauer, A., Engelhardt, O. G., García-Sástre, A., and Palese, P. (1995) Mucosal model of immunization against human immunodeficiency virus type 1 with a chimeric influenza virus. J. Virol. 69, 6678-6686
67. Eckhart, L., Raffelsberger, W., Ferko, B., Klima, A., Purtscher, M., Katinger, H., and Rüker, F. (1996) Immunogenic presentation of a conserved gp41 epitope of human immunodeficiency virus type 1 on recombinant surface antigen of hepatitis B virus. J. Gen. Virol. 77, 2001-2008
68. Kusov, Y. Y., Zamjatina, N. A., Poleschuk, V. F., Michailov, M. I., Morace, G., Eberle, J., and Gauss-Müller, V. (2007) Immunogenicity of a chimeric hepatitis A virus (HAV) carrying the HIV gp41 epitope 2F5. Antiviral Res. 73, 101-111
69. Marusic, C., Rizza, P., Lattanzi, L., Mancini, C., Spada, M., Belardelli, F., Benvenuto, E., and Capone, I. (2001) Chimeric plant virus particles as immunogens for inducing murine and human immune responses against human immunodeficiency virus type 1. J. Virol. 75, 8434-8439
70. Muster, T., Guinea, R., Trkola, A., Purtscher, M., Klima, A., Steindl, F., Palese, P., and Katinger, H. (1994) Cross-neutralizing activity against divergent human immunodeficiency virus type 1 isolates induced by the gp41 sequence ELDKWAS. J. Virol. 68, 4031-4034
71. Zhang, H., Huang, Y., Fayad, R., Spear, G. T., and Qiao, L. (2004) Induction of mucosal and systemic neutralizing antibodies against human immunodeficiency virus type 1 (HIV-1) by oral immunization with bovine papillomavirus-HIV-1 gp41 chimeric virus-like particles. J. Virol. 78, 8342-8348
72. Kim, M., Qiao, Z., Yu, J., Montefiori, D., and Reinherz, E. L. (2007) Immunogenicity of recombinant human immunodeficiency virus type 1-like particles expressing gp41 derivatives in a pre-fusion state. Vaccine 25, 5102-5114
73. Luo, M., Yuan, F., Liu, Y., Jiang, S., Song, X., Jiang, P., Yin, X., Ding, M., and Deng, H. (2006) Induction of neutralizing antibody against human immunodeficiency virus type 1 (HIV-1) by immunization with gp41 membrane-proximal external region (MPER) fused with porcine endogenous retrovirus (PERV) p15E fragment. Vaccine 24, 435-442
74. Jain, S., Patrick, A. J., and Rosenthal, K. L. (2010) Multiple tandem copies of conserved gp41 epitopes incorporated in gag virus-like particles elicit systemic and mucosal antibodies in an optimized heterologous vector delivery regimen. Vaccine 28, 7070-7080
75. Kamdem Toukam, D., Tenbusch, M., Stang, A., Temchura, V., Storcksdieck Genannt Bonsmann, M., Grewe, B., Koch, S., Meyerhans, A., Nchinda, G., Kaptue, L., and Uberla, K. (2012) Targeting antibody responses to the membrane proximal external region of the envelope glycoprotein of human immunodeficiency virus. PLoS One 7, e38068
76. Arnold, G. F., Velasco, P. K., Holmes, A. K., Wrin, T., Geisler, S. C., Phung, P., Tian, Y., Resnick, D. A., Ma, X., Mariano, T. M., Petropoulos, C. J., Taylor, J. W., Katinger, H., and Arnold, E. (2009) Broad neutralization of human immunodeficiency virus type 1 (HIV-1) elicited from human rhinoviruses that display the HIV-1 gp41 ELDKWA epitope. J. Virol. 83, 5087-5100
77. Bomsel, M., Tudor, D., Drillet, A. S., Alfsen, A., Ganor, Y., Roger, M. G., Mouz, N., Amacker, M., Chalifour, A., Diomede, L., Devillier, G., Cong, Z., Wei, Q., Gao, H., Qin, C., Yang, G. B., Zurbriggen, R., Lopalco, L., and Fleury, S. (2011) Immunization with HIV-1 gp41 subunit virosomes induces mucosal antibodies protecting nonhuman primates against vaginal SHIV challenges. Immunity 34, 269-280
78. Yi, G., Lapelosa, M., Bradley, R., Mariano, T. M., Dietz, D. E., Hughes, S., Wrin, T., Petropoulos, C., Gallicchio, E., Levy, R. M., Arnold, E., and Arnold, G. F. (2013) Chimeric rhinoviruses displaying MPER epitopes elicit anti-HIV neutralizing responses. PLoS One 8, e72205
79. Law, M., Cardoso, R. M., Wilson, I. A., and Burton, D. R. (2007) Antigenic and immunogenic study of membrane-proximal external region-grafted gp120 antigens by a DNA prime-protein boost immunization strategy. J. Virol. 81, 4272-4285
80. Coëffier, E., Clément, J. M., Cussac, V., Khodaei-Boorane, N., Jehanno, M., Rojas, M., Dridi, A., Latour, M., El Habib, R., Barré-Sinoussi, F., Hofnung, M., and Leclerc, C. (2000) Antigenicity and immunogenicity of the HIV-1 gp41 epitope ELDKWA inserted into permissive sites of the MalE protein. Vaccine 19, 684-693
81. Liang, X., Munshi, S., Shendure, J., Mark, G., 3rd, Davies, M. E., Freed, D. C., Montefiori, D. C., and Shiver, J. W. (1999) Epitope insertion into variable loops of HIV-1 gp120 as a potential means to improve immunogenicity of viral envelope protein. Vaccine 17, 2862-2872
82. Mantis, N. J., Kozlowski, P. A., Mielcarz, D. W., Weissenhorn, W., and Neutra, M. R. (2001) Immunization of mice with recombinant gp41 in a systemic prime/mucosal boost protocol induces HIV-1-specific serum IgG and secretory IgA antibodies. Vaccine 19, 3990-4001
83. Hinz, A., Schoehn, G., Quendler, H., Hulsik, D. L., Stiegler, G., Katinger, H., Seaman, M. S., Montefiori, D., and Weissenhorn, W. (2009) Characterization of a trimeric MPER containing HIV-1 gp41 antigen. Virology 390, 221-227
84. Behrendt, R., Fiebig, U., Kurth, R., and Denner, J. (2012) Induction of antibodies binding to the membrane proximal external region of gp36 of HIV-2. Intervirology 55, 252-256
85. Dennison, S. M., Sutherland, L. L., Jaeger, F. H., Anasti, K. M., Parks, R., Stewart, S., Bowman, C., Xia, S. M., Zhang, R., Shen, X., Scearce, R. M., Ofek, G., Yang, Y., Kwong, P. D., Santra, S., Liao, H. X., Tomaras, G., Letvin, N. L., Chen, B., Alam, S. M., and Haynes, B. F. (2011) Induction of antibodies in rhesus macaques that recognize a fusion-intermediate conformation of HIV-1 gp41. PLoS One 6, e27824
86. Lutje Hulsik, D., Liu, Y. Y., Strokappe, N. M., Battella, S., El Khattabi, M., McCoy, L. E., Sabin, C., Hinz, A., Hock, M., Macheboeuf, P., Bonvin, A. M., Langedijk, J. P., Davis, D., Forsman Quigley, A., Aasa-Chapman, M. M., Seaman, M. S., Ramos, A., Poignard, P., Favier, A., Simorre, J. P., Weiss, R. A., Verrips, C. T., Weissenhorn, W., and Rutten, L. (2013) A gp41 MPER-specific llama VHH requires a hydrophobic CDR3 for neutralization but not for antigen recognition. PLoS Pathog. 9, e1003202
87. Samygina, V. R., Sokolov, A. V., Bourenkov, G., Petoukhov, M. V., Pulina, M. O., Zakharova, E. T., Vasilyev, V. B., Bartunik, H., and Svergun, D. I. (2013) Ceruloplasmin: macromolecular assemblies with iron-containing acute phase proteins. PLoS One 8, e67145
88. Wang, J., Tong, P., Lu, L., Zhou, L., Xu, L., Jiang, S., and Chen, Y. H. (2011) HIV-1 gp41 core with exposed membrane-proximal external region inducing broad HIV-1 neutralizing antibodies. PLoS One 6, e18233
89. Srivastava, I. K., Stamatatos, L., Legg, H., Kan, E., Fong, A., Coates, S. R., Leung, L., Wininger, M., Donnelly, J. J., Ulmer, J. B., and Barnett, S. W. (2002) Purification and characterization of oligomeric envelope glycoprotein from a primary R5 subtype B human immunodeficiency virus. J. Virol. 76, 2835-2847
90. Weissenhorn, W., Calder, L. J., Dessen, A., Laue, T., Skehel, J. J., and Wiley, D. C. (1997) Assembly of a rod-shaped chimera of a trimeric GCN4 zipper and the HIV-1 gp41 ectodomain expressed in Escherichia coli. Proc. Natl. Acad. Sci. U.S.A. 94, 6065-6069
91. Frey, G., Chen, J., Rits-Volloch, S., Freeman, M. M., Zolla-Pazner, S., and Chen, B. (2010) Distinct conformational states of HIV-1 gp41 are recognized by neutralizing and non-neutralizing antibodies. Nat. Struct. Mol. Biol. 17, 1486-1491
92. Konarev, P. V., Petoukhov, M. V., Volkov, V. V., and Svergun, D. I. (2006) ATSAS 2.1, a program package for small-angle scattering data analysis. J. Appl. Crystallogr. 39, 277-286
93. Putnam, C. D., Hammel, M., Hura, G. L., and Tainer, J. A. (2007) X-ray solution scattering (SAXS) combined with crystallography and computation: defining accurate macromolecular structures, conformations and assemblies in solution. Q. Rev. Biophys. 40, 191-285
94. Konarev, P. V., Volkov, V. V., Sokolova, A. V., Koch, M. H. J., and Svergun, D. I. (2003) PRIMUS: a Windows PC-based system for small-angle scattering data analysis. J. Appl. Crystallogr. 36, 1277-1282
95. Svergun, D. I. (1992) Determination of the regularization parameter in indirect-transform methods using perceptual criteria. J. Appl. Crystallogr. 25, 495-503
96. Svergun, D. I. (1999) Restoring low resolution structure of biological macromolecules from solution scattering using simulated annealing. Biophys. J. 76, 2879-2886
97. Brügger, B., Glass, B., Haberkant, P., Leibrecht, I., Wieland, F. T., and Kräusslich, H. G. (2006) The HIV lipidome: a raft with an unusual composition. Proc. Natl. Acad. Sci. U.S.A. 103, 2641-2646
98. Lai, R. P., Seaman, M. S., Tonks, P., Wegmann, F., Seilly, D. J., Frost, S. D., LaBranche, C. C., Montefiori, D. C., Dey, A. K., Srivastava, I. K., Sattentau, Q., Barnett, S. W., and Heeney, J. L. (2012) Mixed adjuvant formulations reveal a new combination that elicit antibody response comparable to Freund's adjuvants. PLoS One 7, e35083
99. Freudenberg, M. A., Fomsgaard, A., Mitov, I., and Galanos, C. (1989) ELISA for antibodies to lipid A, lipopolysaccharides and other hydrophobic antigens. Infection 17, 322-328
100. Li, M., Gao, F., Mascola, J. R., Stamatatos, L., Polonis, V. R., Koutsoukos, M., Voss, G., Goepfert, P., Gilbert, P., Greene, K. M., Bilska, M., Kothe, D. L., Salazar-Gonzalez, J. F., Wei, X., Decker, J. M., Hahn, B. H., and Montefiori, D. C. (2005) Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies. J. Virol. 79, 10108-10125
101. Edmonds, T. G., Ding, H., Yuan, X., Wei, Q., Smith, K. S., Conway, J. A., Wieczorek, L., Brown, B., Polonis, V., West, J. T., Montefiori, D. C., Kappes, J. C., and Ochsenbauer, C. (2010) Replication competent molecular clones of HIV-1 expressing Renilla luciferase facilitate the analysis of antibody inhibition in PBMC. Virology 408, 1-13
102. Weissenhorn, W., Wharton, S. A., Calder, L. J., Earl, P. L., Moss, B., Aliprandis, E., Skehel, J. J., and Wiley, D. C. (1996) The ectodomain of HIV-1 env subunit gp41 forms a soluble, α-helical, rod-like oligomer in the absence of gp120 and the N-terminal fusion peptide. EMBO J. 15, 1507-1514
103. Cole, K. S., Rowles, J. L., Jagerski, B. A., Murphey-Corb, M., Unangst, T., Clements, J. E., Robinson, J., Wyand, M. S., Desrosiers, R. C., and Montelaro, R. C. (1997) Evolution of envelope-specific antibody responses in monkeys experimentally infected or immunized with simian immunodeficiency virus and its association with the development of protective immunity. J. Virol. 71, 5069-5079
104. Weissenhorn, W., Hinz, A., and Gaudin, Y. (2007) Virus membrane fusion. FEBS Lett. 581, 2150-2155
105. Reardon, P. N., Sage, H., Dennison, S. M., Martin, J. W., Donald, B. R., Alam, S. M., Haynes, B. F., and Spicer, L. D. (2014) Structure of an HIV-1-neutralizing antibody target, the lipid-bound gp41 envelope membrane proximal region trimer. Proc. Natl. Acad. Sci. U.S.A. 111, 1391-1396
106. Liu, J., Bartesaghi, A., Borgnia, M. J., Sapiro, G., and Subramaniam, S. (2008) Molecular architecture of native HIV-1 gp120 trimers. Nature 455, 109-113
107. Meyerson, J. R., Tran, E. E., Kuybeda, O., Chen, W., Dimitrov, D. S., Gorlani, A., Verrips, T., Lifson, J. D., and Subramaniam, S. (2013) Molecular structures of trimeric HIV-1 Env in complex with small antibody derivatives. Proc. Natl. Acad. Sci. U.S.A. 110, 513-518
108. Julien, J. P., Bryson, S., Nieva, J. L., and Pai, E. F. (2008) Structural details of HIV-1 recognition by the broadly neutralizing monoclonal antibody 2F5: epitope conformation, antigen-recognition loop mobility, and an-ion-binding site. J. Mol. Biol. 384, 377-392
109. Scherer, E. M., Zwick, M. B., Teyton, L., and Burton, D. R. (2007) Difficulties in eliciting broadly neutralizing anti-HIV antibodies are not explained by cardiolipin autoreactivity. AIDS 21, 2131-2139
110. Buiting, A. M., van Rooijen, N., and Claassen, E. (1992) Liposomes as antigen carriers and adjuvants in vivo. Res. Immunol. 143, 541-548
111. Fortin, A., and Thérien, H. M. (1993) Mechanism of liposome adjuvanticity: an in vivo approach. Immunobiology 188, 316-322
112. Dey, A. K., Burke, B., Sun, Y., Hartog, K., Heeney, J. L., Montefiori, D., Srivastava, I. K., and Barnett, S. W. (2012) Use of a polyanionic carbomer, Carbopol971P, in combination with MF59, improves antibody responses to HIV-1 envelope glycoprotein. Vaccine 30, 2749-2759
113. Binley, J. M., Wrin, T., Korber, B., Zwick, M. B., Wang, M., Chappey, C., Stiegler, G., Kunert, R., Zolla-Pazner, S., Katinger, H., Petropoulos, C. J., and Burton, D. R. (2004) Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies. J. Virol. 78, 13232-13252
114. Choudhry, V., Zhang, M. Y., Harris, I., Sidorov, I. A., Vu, B., Dimitrov, A. S., Fouts, T., and Dimitrov, D. S. (2006) Increased efficacy of HIV-1 neutralization by antibodies at low CCR5 surface concentration. Biochem. Biophys. Res. Commun. 348, 1107-1115
115. Bonsignori, M., Moody, M. A., Parks, R. J., Holl, T. M., Kelsoe, G., Hicks, C. B., Vandergrift, N., Tomaras, G. D., and Haynes, B. F. (2009) HIV-1 envelope induces memory B cell responses that correlate with plasma antibody levels after envelope gp120 protein vaccination or HIV-1 infection. J. Immunol. 183, 2708-2717
116. Pastori, C., Tudor, D., Diomede, L., Drillet, A. S., Jegerlehner, A., Rohn, T. A., Bomsel, M., and Lopalco, L. (2012) Virus like particle based strategy to elicit HIV-protective antibodies to the α-helical regions of gp41. Virology 431, 1-11
117. Dawood, R., Benjelloun, F., Pin, J. J., Kone, A., Chanut, B., Jospin, F., Lucht, F., Verrier, B., Moog, C., Genin, C., and Paul, S. (2013) Generation of HIV-1 potent and broad neutralizing antibodies by immunization with postfusion HR1/HR2 complex. AIDS 27, 717-730